Global Prefilled Syringes Market

Prefilled Syringes Market Size, Share, Growth Analysis, By Type(Conventional Prefilled Syringes [Disposable Prefilled Syringes, Reusable Prefilled Syringes], Safety Prefilled Syringes), By Design(Single-chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes, and Customized Prefilled Syringes), By Material(Glass Prefilled Syringes, Plastic Prefilled Syringes), By Application(Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer), By Region - Industry Forecast 2024-2031


Report ID: SQSG35B2013 | Region: Global | Published Date: September, 2024
Pages: 274 | Tables: 114 | Figures: 77

Prefilled Syringes Market Dynamics

Prefilled Syringes Market Driver

Increasing Demand for Vaccines and Immunizations 

  • Increasing incidence of chronic diseases such as diabetes mellitus, rheumatoid arthritis and rheumatoid arthritis has created demand for vaccines which are commonly administered by injection has increased dramatically. The demand for prefilled syringes has been amplified. The power of a syringe a controlled packaging can reduce the risk of contamination and minimize dose errors makes it the best option for vaccines and therapeutics strong application in nature, leading to market growth. 

Technological Advances in Drug Delivery Systems  

  • New trends in the design and use of prefilled syringes make them attractive in various health care settings. Pharmaceutical companies focus on products such as glass-polymer-based syringes with needle safety features including needle safety systems and simple automatic devices. The emergence of smart prefilled syringes with integrated technologies, such as dose tracking and digital connectivity, is transforming the drug delivery landscape.  

Restraints 

Increased Manufacturing Costs and Complex Regulatory Requirements 

  • Compared to conventional syringes or containers, pre-filled syringes must be manufactured requiring stricter quality assurance systems and adherence to regulatory standards to ensure the sterile, dose accuracy, and patient safety. Additionally, manufacturers must comply with regulatory guidelines in different regions, which may lead to longer approval times and higher manufacturing costs. 

Handling and Storage Challenges 

  • Prefilled syringes are sensitive to temperature fluctuations, which can affect formulation stability and syringe integrity. Special conditions for storage, such as refrigeration for biologics, adds logistical challenges to the supply of pre-filled syringes as well as degradation or possible handling, thereby reducing drug effectiveness. These challenges in terms of handling and storage are barriers to widespread use of prefilled syringes, especially in low-volume settings.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Prefilled Syringes Market size was valued at USD 6.8 billion in 2022 and is poised to grow from USD 7.52 billion in 2023 to USD 16.84 billion by 2031, growing at a CAGR of 10.60% during the forecast period (2024-2031).

The prefilled syringes market is particularly competitive and dynamic, with each installed pharmaceutical giants and specialized medical tool agencies actively engaged in driving innovation, enhancing patient safety, and increasing their international presence. These competitive environments are fashioned by way of elements such as technological advancements, strategic partnerships, acquisitions, and the consistent need for addressing stringent regulatory requirements. 'BD (US) ', 'Gerresheimer AG (Germany) ', 'SCHOTT (Germany) ', 'West Pharmaceutical Services, Inc. (US) ', 'AptarGroup, Inc. (US) ', 'Nipro (Japan) ', 'Baxter (Simtra) (US) ', 'Owen Mumford Ltd. (UK) ', 'Weigao Medical International Co., Ltd. (China) ', 'Credence MedSystems, Inc. (US) ', 'Novartis AG (Switzerland) ', 'Stevanato Group (Italy) ', 'Poly Medicure (India) ', 'MedXL Inc. (Canada) ', 'Sharps Technology, Inc. (US) ', 'Fresenius Kabi USA (US) ', 'Medefil, Inc. (US) ', 'D.B.M. S.R.L. (Italy) ', 'Taisei Kako Co., Ltd. (Japan) ', 'Shandong Province Medicinal Glass Co., Ltd. (China) ', 'Shin Yan Sheno Precision Industrial Co., Ltd. (Taiwan) ', 'J.O. Pharma Co., Ltd. (Otsuka Holdings Co., Ltd.) (Japan) ', 'BMI Korea (South Korea) ', 'Al Shifa Medical Products Co. (Saudi Arabia)'

Increasing incidence of chronic diseases such as diabetes mellitus, rheumatoid arthritis and rheumatoid arthritis has created demand for vaccines which are commonly administered by injection has increased dramatically. The demand for prefilled syringes has been amplified. The power of a syringe a controlled packaging can reduce the risk of contamination and minimize dose errors makes it the best option for vaccines and therapeutics strong application in nature, leading to market growth. 

Transition to Polymer-Based Prefilled Syringes: Traditionally glass has been the preferred material for prefilled syringes, due to its inertness and compatibility with a wide range of chemicals but polymer-based prefilled syringes are gaining popularity. Polymeric materials such as cyclic olefin polymers (COP) and cyclic olefin copolymers (COCs) increase strength and reduce the risk of contamination from glass breakage. These materials are particularly useful for biologics and complex pharmaceuticals requiring accurate and robust quantification. The trend toward polymer-based syringes is expected to increase as pharmaceutical companies seek safer and more durable products than glass. 

North America region in the prefilled syringes market share is 32.3% in 2023. Prevention of needlestick injuries by healthcare professionals is a priority in developed countries including the US. and Canada including in pre-filled syringes with needle guards decrease the likelihood of this injury. Centers for Disease Control for Vaccine Administration owing to their ability to preserve vaccine potency over a long period of time and shelf life driving the market growth. North America accounted for the largest share of the pre-filled syringes market in 2023. Also, injection devices, improved medication regimens, technological advances, routine prescriptions of self-administered devices and Prevention (CDC) recommendations are expected to deliver the market has developed. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Prefilled Syringes Market

Report ID: SQSG35B2013

$5,300
BUY NOW GET FREE SAMPLE